Interest in precision diagnostics has been fuelled by the concept that early detection of
cancer would benefit patients; that is, if detected early, more tumours should be resectable …

Acute pancreatitis (AP) is a severe inflammation of the pancreas presented with sudden
onset and severe abdominal pain with a high morbidity and mortality rate, if accompanied by …

Purpose Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with a 5-year
survival of< 10% because of diffuse symptoms leading to late-stage diagnosis. That survival …

The nature of protein microarray platforms is favorable for multiplexing, leading to the
development of tools for personalised medicine and highly precise diagnostics. However, to …

Background Chronic pancreatitis (CP) does not have diagnostic or prognostic biomarkers.
CP is the end stage of a progressive inflammatory syndrome that is diagnosed at late stages …

Simple Summary Pancreatic ductal adenocarcinoma is a very lethal tumor entity with the late
appearance of clinical signs and the absence of biomarkers for early diagnosis. Diabetes …

The human body is composed not only of human cells but is occupied by bacteria, archaea,
fungi, and viruses; this ensemble of organisms (microbiota) and their expressed genes are …

Blood is an ideal body fluid for the discovery or monitoring of diagnostic and prognostic
protein biomarkers. However, discovering robust biomarkers requires the analysis of large …

Introduction Around 20% of individuals diagnosed with acute pancreatitis (AP) may develop
severe acute pancreatitis (SAP), possibly resulting in a mortality rate ranging from 15% to …

Aiming at clinical studies of human diseases, antibody-assisted assays have been applied
to biomarker discovery and toward a streamlined translation from patient profiling to assays …